Glenview Trust Co’s Abbvie Inc Position
Does Glenview Trust Co own Abbvie Inc (ABBV)? Yes — 421.3K shares worth $92M (+1.44% of its 13F portfolio) as of Q1 2026, up from 415.3K shares the prior filed quarter.
Position Value
$92M
Q1 2026
Shares
421.3K
% of Portfolio
+1.44%
Quarters Held
30
currently held
Position History ABBV
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 421.3K | $92M | +1.44% |
| Q4 2025 | 415.3K | $95M | +1.46% |
| Q3 2025 | 414.1K | $96M | +1.52% |
| Q2 2025 | 421.5K | $78M | +1.35% |
| Q1 2025 | 413.1K | $87M | +1.68% |
| Q4 2024 | 411.1K | $73M | +1.37% |
| Q3 2024 | 409.8K | $81M | +1.56% |
| Q2 2024 | 407.1K | $70M | +1.41% |
| Q1 2024 | 404.6K | $74M | +1.58% |
| Q4 2023 | 391.8K | $61M | +1.49% |
| Q3 2023 | 377.0K | $56M | +1.55% |
| Q2 2023 | 361.8K | $49M | +1.33% |
| Q1 2023 | 357.0K | $57M | +1.70% |
| Q4 2022 | 353.7K | $57M | +1.89% |
| Q3 2022 | 346.4K | $46M | +1.76% |
| Q2 2022 | 340.7K | $52M | +1.92% |
| Q1 2022 | 335.7K | $54M | +1.77% |
| Q4 2021 | 311.9K | $42M | +1.40% |
| Q3 2021 | 318.4K | $34M | +1.33% |
| Q2 2021 | 305.0K | $34M | +1.33% |
| Q1 2021 | 188.7K | $20M | +0.88% |
| Q4 2020 | 186.0K | $20M | +0.93% |
| Q3 2020 | 185.9K | $16M | +0.84% |
| Q2 2020 | 187.5K | $18M | +1.05% |
| Q1 2020 | 186.9K | $14M | +0.99% |
| Q4 2019 | 191.4K | $17M | +0.95% |
| Q3 2019 | 186.3K | $14M | +0.85% |
| Q2 2019 | 187.9K | $14M | +0.85% |
| Q1 2019 | 195.3K | $16M | +1.01% |
| Q4 2018 | 205.3K | $19M | +1.40% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Glenview Trust Co’s full portfolio or all institutional holders of ABBV.